Pedro Delgado
Family · Horsham, PANPI 1558806075
Payments from drug & device makers
Across 75 payments — averaging $19.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$519
- Medtronic$115
- Lilly USA, LLC$84
- Bayer$81
- AstraZeneca$64
- Boehringer Ingelheim$60
- plus $558 from 16 others
What the payments were for
- Food & beverage$1,45698%
- Education$252%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 26 | $519 |
| Medtronic | 5 | $115 |
| Lilly USA, LLC | 5 | $84 |
| Bayer | 5 | $81 |
| AstraZeneca | 4 | $64 |
| Boehringer Ingelheim | 3 | $60 |
| AbbVie | 3 | $60 |
| Axsome Therapeutics, Inc. | 2 | $59 |
| Vanda Pharmaceuticals Inc. | 3 | $55 |
| Alkermes, Inc. | 2 | $48 |
| E.r. Squibb & Sons, L.L.C. | 2 | $46 |
| Johnson & Johnson | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Pfizer | 2 | $37 |
| GSK | 2 | $28 |
| Corcept Therapeutics | 1 | $26 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
| Merck | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$1,481 in reported general payments places this provider in the 75th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 265 | $288,421 |
| EliquisApixaban | 88 | $81,336 |
| JardianceEmpagliflozin | 63 | $75,301 |
| JanuviaSitagliptin Phosphate | 45 | $54,097 |
| LinzessLinaclotide | 78 | $50,429 |
| Breo ElliptaFluticasone/Vilanterol | 80 | $31,640 |
| EntrestoSacubitril/Valsartan | 31 | $31,252 |
| OzempicSemaglutide | 29 | $28,288 |
| MounjaroTirzepatide | 26 | $27,602 |
| Spiriva RespimatTiotropium Bromide | 53 | $26,609 |
| FarxigaDapagliflozin Propanediol | 39 | $26,522 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 40 | $25,629 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 268 | $25,615 |
| XareltoRivaroxaban | 40 | $23,243 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 145 | $23,166 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $84 | $316,023291 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta | $60 | $121,414138 claims |
| PfizerEliquis | $37 | $81,33688 claims |
| MerckJanuvia, Janumet, Dulera | $18 | $77,19580 claims |
| GSKBreo Ellipta, Trelegy Ellipta, Arnuity Ellipta | $28 | $66,571166 claims |
| AbbVieLinzess | $60 | $50,42978 claims |
| AstraZenecaFarxiga, Symbicort | $64 | $33,88772 claims |
| Novo NordiskOzempic | $519 | $28,28829 claims |
| Johnson & JohnsonXarelto | $44 | $23,24340 claims |
| Astellas Pharma US IncMyrbetriq | $21 | $5,07712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,717 family providers in Pennsylvania.
Other family in Horsham
- Helen GodfreyHorsham$39K
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.